American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function by Alonso, Alvaro et al.
American Heart Association’s Life’s Simple 7: Avoiding Heart 
Failure and Preserving Cardiac Structure and Function
Aaron R. Folsom, MDa, Amil M. Shah, MDb, Pamela L. Lutsey, PhDa, Nicholas S. Roetker, 
MPHa, Alvaro Alonso, MD, PhDa, Christy L. Avery, PhDc, Michael D. Miedema, MDd, Suma 
Konety, MDe, Patricia P. Chang, MDf, and Scott D. Solomon, MDb
a Division of Epidemiology and Community Health, School of Public Health, University of 
Minnesota, Minneapolis, Minnesota
b Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, 
Massachusetts
c Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina
d Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
e Cardiology Division, University of Minnesota Medical School, Minneapolis, Minnesota
f Division of Cardiology, Department of Medicine, University of North Carolina, Chapel Hill, North 
Carolina
Abstract
BACKGROUND—Many people may underappreciate the role of lifestyle in avoiding heart 
failure. We estimated whether greater adherence in middle age to American Heart Association’s 
Life’s Simple 7 guidelines -- on smoking, body mass, physical activity, diet, cholesterol, blood 
pressure, and glucose -- is associated with lower lifetime risk of heart failure and greater 
preservation of cardiac structure and function in old age.
METHODS—We studied the population-based Atherosclerosis Risk in Communities Study 
cohort of 13,462 adults aged 45-64 years in 1987-89. From the 1987-89 risk factor measurements, 
we created a Life’s Simple 7 score (range 0-14, giving 2 points for ideal, 1 point for intermediate, 
and 0 points for poor components). We identified 2,218 incident heart failure events using 
surveillance of hospital discharge and death codes through 2011.
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In addition, in 4,855 participants free of clinical cardiovascular disease in 2011-13, we performed 
echocardiography from which we quantified left ventricular hypertrophy and diastolic 
dysfunction.
RESULTS—One in four participants (25.5%) developed heart failure through age 85. Yet, this 
lifetime heart failure risk was 14.4% for those with a middle-age Life’s Simple 7 score of 10-14 
(optimal), 26.8% for a score of 5-9 (average), and 48.6% for a score of 0-4 (inadequate). Among 
those with no clinical cardiovascular event, the prevalence of left ventricular hypertrophy in late 
life was approximately 40% as common, and diastolic dysfunction was approximately 60% as 
common, among those with an optimal middle-age Life’s Simple 7 score compared with an 
inadequate score.
CONCLUSIONS—Greater achievement of American Heart Association’s Life’s Simple 7 in 
middle-age is associated with a lower lifetime occurrence of heart failure and greater preservation 
of cardiac structure and function.
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Americans’ lifetime risk of heart failure is substantial. Epidemiologists have estimated that 
lifetime risk of heart failure was one in five in the Framingham Heart Study,1 one in three in 
the Rotterdam Study,2 and 20-45% among various sex-ethnic groups in the Cardiovascular 
Lifetime Risk Pooling Project.3 Because heart failure risk is so high, primary prevention 
must be a public health priority.
For primary prevention of overall cardiovascular disease, the American Heart Association 
(AHA) recommends that Americans follow “Life’s Simple 7.” Life’s Simple 7 describe 
ideal, intermediate and poor levels of cardiovascular disease risk factors or behaviors, 
namely, smoking, body mass index, physical activity, diet, total cholesterol, blood pressure, 
and fasting serum glucose.4 The Atherosclerosis Risk in Communities (ARIC) Study 
documented that the number of ideal Simple 7 factors achieved is associated strongly and 
inversely with later incidence of total cardiovascular disease,5 heart failure,6,7 and cancer.8 
Yet, no publication, to our knowledge, has specifically addressed the degree to which 
following Life’s Simple 7 might lower lifetime heart failure risk or preserve cardiac 
structure and function to old age.
We therefore analyzed ARIC data, with longer follow-up than previously available, to 
examine whether greater adherence to Life’s Simple 7 in middle age is associated with (a) 
reduced incidence rates and lifetime risk of heart failure and (b) greater preservation of 




The ARIC Study9 enrolled 15,792 men and women aged 45 to 64 years in 1987-1989, in 
four U.S. communities: Forsyth Co., NC, Jackson, MS (African Americans only), suburban 
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Minneapolis, MN, and Washington Co., MD. The investigators followed the cohort for 
incident cardiovascular disease events and conducted four subsequent examinations, 
including an echocardiogram at Visit 5 in 2011-2013, approximately 25 years after baseline. 
The institutional review committees at each study center approved the methods, and staff 
obtained informed participant consent.
Measurement of Life’s Simple 7
We used the ARIC baseline visit, when participants were middle-aged, as the point for 
assessment and classification of Life’s Simple 7 characteristics. Measurements included a 
food frequency questionnaire, physical activity, body mass index, smoking, total cholesterol, 
seated blood pressure after a 5 minute rest, and fasting glucose.9 We classified each factor 
according to AHA’s Simple 7 categories of ideal, intermediate, or poor.4,5 (Supplemental 
Table) For example, the respective ideal, intermediate, and poor body mass categories are 
<25, 25-29.99, and ≥30 kg/m3.
Heart Failure and Myocardial Infarction Occurrence
We defined preexisting heart failure at baseline as the following: (a) an affirmative response 
to “Were any of the medications you took during the last 2 weeks for heart failure?” or (b) 
Stage 3 or “manifest heart failure,” based on symptoms and signs, using Gothenburg 
criteria.10,11 We defined preexisting coronary heart disease at baseline by self-reported prior 
physician diagnosis of myocardial infarction or coronary revascularization, or by prevalent 
myocardial infarction by 12-lead ECG.
To identify incident events through December 31, 2011, ARIC staff contacted participants 
annually, identified hospitalizations and deaths during the prior year, and surveyed discharge 
lists from local hospitals and death certificates from state vital statistics offices.12 We 
defined incident heart failure as the first occurrence of either a hospitalization that included 
an International Classification of Diseases, 9th Revision (ICD-9) discharge code of 428 
(428.0 to 428.9) among the primary or secondary diagnoses or else a death certificate with 
an ICD-9 code of 428 or an ICD-10 code of I50 among the listed or underlying causes of 
death.11 Incident myocardial infarction was defined by combinations of chest pain 
symptoms, ECG changes, and cardiac biomarkers.12
Visit 5 Echocardiographic Data
Using the same model of equipment, trained echo technicians in the four ARIC sites 
obtained images in the parasternal long- and short-axis and apical 4-chamber views.13 We 
measured, in triplicate from the 2D views, left ventricular dimensions, volumes, and wall 
thickness, and took Doppler measures of mitral inflow and mitral annular relaxation 
velocities following the recommendations of the American Society of Echocardiography 
(ASE).14
For this report, we focused on three echocardiographic measures obtained in 2011-2013 — 
left ventricular hypertrophy, left ventricular systolic dysfunction, and left ventricular 
diastolic dysfunction — among participants at Visit 5 with no history of heart failure or 
myocardial infarction through 2011. ARIC determined left ventricular mass according to 
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ASE recommendations and indexed to height to the power of 2.7. We then defined left 
ventricular hypertrophy as left ventricular mass indexed to body surface area >95 g/m2 in 
women and >115 g/m2 in men. We defined systolic dysfunction as an left ventricular 
ejection fraction <50%. We defined diastolic dysfunction as a ratio of E wave velocity to 
early mitral annular relaxation velocity assessed at the septal mitral annulus (E/E′ratio) >15, 
which previous research showed accurately identifies left ventricular diastolic pressure.15
Statistical Analysis
We categorized baseline (middle-age) achievement of Life’s Simple 7 in two ways for 
analysis. Firstly, we simply counted the number of ideal Life’s Simple 7 components 
(Supplemental Table) that each participant met. Secondly, we a priori created a score, used 
in previous studies,16 in which each component was given points of 0, 1, or 2 to represent 
poor, intermediate, or ideal health categories, respectively, and these were summed to yield 
a Life’s Simple 7 score. This score was grouped as 0-4 (inadequate), 5-9 (average), and 
10-14 (optimal) for cardiovascular health.
Analysis of Heart Failure Occurrence
Of the 15,792 participants at ARIC baseline, we excluded those who were: not white or 
African American (n=48), had prevalent heart failure (n=751) or uncertain heart failure 
status (n=284), were not fasting for 8 hours (n=461), had missing dietary data or had 
implausible energy intake (n=298), had incomplete information on other Life’s Simple 7 
components (n=371), or had uncertain myocardial infarction status (n=117). This left 13,462 
participants (n=10,194 whites and 3,268 African Americans) for the present analyses 
relating Life’s Simple 7 to incident heart failure.
Except where indicated, we used SAS, Version 9.3 (SAS Institute, Inc., Cary, NC) for 
analyses. We calculated incidence rates of heart failure and 95% confidence intervals using 
Poisson regression. We calculated hazard ratios and 95% confidence intervals of incident 
heart failure using a Cox proportional hazards model that accounted for the competing risk 
of death,17 via the stcrreg function in Stata, release 12 (StataCorp, College Station, TX). We 
estimated lifetime risk of heart failure using a published method,18 which employs a Kaplan 
Meier analysis that incorporates competing risks, with deaths from other causes as 
competing events. One of the assumptions of this competing risk model is that each failure 
mechanism leading to a particular type of failure (i.e., failure mode) proceeds independently 
of every other one, at least until a failure occurs. We estimated lifetime risk for heart failure 
from age 45 to age 85 years, with death free of heart failure as the competing event. Because 
the ARIC age range at baseline was broad, we also computed age-stratified estimates which 
verified no birth cohort effects.
Analysis of Cardiac Structure and Function
Of the 6,538 participants at Visit 5 (response rate=65% of ARIC participants still alive), we 
restricted the sample to 5,758 who had complete data for echocardiography and middle-aged 
data for Life’s Simple 7. We then excluded participants with heart failure present or missing 
at baseline (n=196), coronary heart disease present or missing at baseline (n=144), incident 
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heart failure (n=297) or myocardial infarction (n=254) through 2011, or race other than 
black or white (n=12), yielding a final sample size of 4,855.
We calculated the prevalences of left ventricular hypertrophy, diastolic dysfunction, and 
systolic dysfunction in relation to Life’s Simple 7 categories, and corresponding odds ratios 
using logistic regression. To adjust for possible bias due to selective attrition before Visit 5 
due to death or dropouts, we calculated inverse probability weights as described in 
Supplemental Methods. We applied the calculated weights to multivariable logistic models 
for each measure of cardiac structure and function with the Life’s Simple 7 score as the 
main independent variable, using robust variance estimators for calculation of 95% 
confidence intervals.
RESULTS
Heart Failure Incidence in Relation to Life’s Simple 7
Among 13,462 ARIC participants initially free of heart failure at ages 45-64, the mean 
(standard deviation) age was 54.1 (5.8) years, 24.3% were African American, and 54.6% 
were women. We followed them for a median of 22.5 years and identified 2,218 incident 
heart failure events. As shown in Table 1, participants having ≥4 ideal components of Life’s 
Simple 7 in middle-age had less than one third the heart failure incidence rate of those with 
no ideal health components. Moreover, each of the 7 ideal components of Life’s Simple 7 
was independently associated with reduced heart failure incidence (data not shown).
The lifetime risk of heart failure, through age 85, was 25.5% (95% CI: 24.1%, 26.6%) 
overall, but it ranged from 12.3% in those with 5-7 ideal components in middle-age to 
approximately 45% for those with 0 ideal components (Table 1). When we excluded 
participants who had coronary heart disease at baseline or an incident myocardial infarction 
during follow-up, lifetime risk was reduced to 21.3% (95% CI: 19.9%, 22.5%) overall, but 
still was strongly related to Life’s Simple 7 (Table 1).
Lifetime heart failure risk was 23.9% (95% CI: 22.4%, 25.2%) in whites and 30.6% (95% 
CI: 27.4, 33.0%) in African Americans. Compared to whites, African Americans were 
proportionately less likely to have ideal cardiovascular health metrics. For example, 887 of 
3,268 African Americans (27.1%) had <2 ideal, among the seven cardiovascular disease 
health metrics, whereas 1,459 of 10,194 whites (14.3%) had <2 ideal metrics (Table 1). Yet, 
within each ideal health frequency group, the incidence rates and lifetime risks of heart 
failure were only slightly higher for African Americans than whites. Thus, the ethnic 
differences in heart failure rates in ARIC appear largely due to higher risk factor levels in 
African Americans than whites.
As shown in Table 2, on the Life’s Simple 7 score (range 0-14, giving 2 points for ideal, 1 
point for intermediate, and 0 points for poor components), 7% of the ARIC sample were 
“inadequate,” 65% “average,” and 28% “optimal.” The Life’s Simple 7 score was strongly 
and inversely associated with incidence and lifetime risk of heart failure. For example, the 
lifetime risk was 14.4% for those with an optimal score of 10-14, 26.8% for those with an 
average score of 5-9, and 48.6% for those with an inadequate score of 0-4. This association 
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was similar (p for interactions in hazard ratios >0.25) for men and women and for African 
Americans and whites (Table 2). Figure 1 further depicts the lifetime risk of heart failure for 
African Americans and whites in relation to the Life’s Simple 7 score.
Cardiac Structure and Function, in Participants Free of Heart Failure and Myocardial 
Infarction, in Relation to Life’s Simple 7
Among the 4,855 ARIC participants free of coronary heart disease at baseline, who did not 
have a clinical heart failure or myocardial infarction event by 2011, the mean (standard 
deviation) Visit 5 age in 2011-2013 was 75.3 (5.1) years, 20.1% were African American, 
and 59.5% were women. On the Visit 5 echocardiogram, 9.4% had left ventricular 
hypertrophy, 19.6% had diastolic dysfunction defined by an E/E′ratio >15, and 1.6% had 
systolic dysfunction. As shown in Table 3, the prevalence of left ventricular hypertrophy in 
those with an optimal Life’s Simple 7 score, in middle age, was 40% that of those with an 
inadequate score (left ventricular hypertrophy 6.7% vs. 16.5%, respectively, adjusted odds 
ratio = 0.37). Diastolic dysfunction at Visit 5 was approximately 60% as common with an 
optimal score (16.2%) versus an inadequate score (27.1%) on Life’s Simple 7 score in 
middle age (adjusted odds ratio = 0.43). Systolic dysfunction was half as common (1.2% for 
optimal versus 2.4% for inadequate), but the adjusted odds ratio was nonsignificant.
DISCUSSION
In this prospective middle-aged cohort followed 25 years, one in four participants sustained 
a hospitalized or fatal heart failure event by age 85 years. However, those, who in middle 
age met more of AHA Life’s Simple 7 metrics, had substantially lower lifetime risk of heart 
failure – approximately 30% of the lifetime risk for those with our “optimal” Life’s Simple 7 
score and 55% of the lifetime risk for an “average” score, compared with an “inadequate” 
score. Furthermore, among those who had not yet sustained a heart failure event or 
myocardial infarction during follow-up through 2011, echocardiographic left ventricular 
hypertrophy in 2011-2013 was 40% as common, diastolic dysfunction was 60% as common, 
and systolic dysfunction nonsignificantly less common for participants with an optimal 
versus an inadequate Life’s Simple 7 score in middle age. This suggests that achieving 
Life’s Simple 7 metrics in mid-life can help preserve cardiac function in late-life.
AHA initiated the Life’s Simple 7 campaign to prevent cardiovascular disease by 
encouraging adults to avoid seven established cardiovascular disease risk factors.4 Greater 
achievement of Life’s Simple 7 is associated not only with lower incidence of heart failure, 
but also with lower rates of coronary heart disease,5 stroke,16 cognitive impairment,19 
diabetes,20 chronic kidney disease,21 and cancer.8 Although few Americans are able to 
achieve all ideal cardiovascular health metrics, due to genetics or lifestyle, acheving some 
ideal or intermediate metrics is associated with better health than is achieving none.
We focused on lifetime risk of heart failure because many health care providers may be 
unaware how high heart failure risk is, and because, compared with traditional incidence 
rates, lifetime risk estimates are less biased by competing mortality.17 Our estimate of 
lifetime heart failure risk by age 85 being one in four is similar to previous studies,1-3 
although estimates vary according to the maximum age cutoff used. We chose 85 years 
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because, so far, few ARIC participants have lived beyond age 90. Regardless of the age 
cutoff, it is apparent that many Americans will develop heart failure, and African Americans 
more than whites.3 Yet, ARIC has demonstrated previously,6 and reconfirmed here, that the 
ethnic disparity in heart failure in this cohort is largely due to African Americans having 
more cardiovascular disease risk factors than whites, as opposed to a greater heart failure 
risk within comparable risk factor categories. Our study’s good news is that greater 
achievement of Life’s Simple 7 in middle-age is associated with reduced heart failure risk in 
both African Americans and whites.
We chose left ventricular hypertrophy, diastolic dysfunction, and systolic dysfunction as the 
echocardiographic parameters, because these are related to greater risk of heart failure and 
mortality and because they limit patients physically. We could have used other ways to 
define diastolic dysfunction, but an E/E′ratio >15 is a reasonable approach.22 Mild diastolic 
dysfunction is common in elderly adults, and it is uncertain how many of the ARIC 
participants with these subclinical abnormalities will suffer untoward consequences. Yet, 
clearly those who achieved more Life Simple 7 metrics in middle-age had better cardiac 
structure and function in late life.
While we provide novel information from a large, carefully assessed cohort, some 
limitations of our study warrant discussion. Firstly, we studied hospitalized or fatal heart 
failure based on ICD codes, as ARIC did not originally plan or have the resources to validate 
all heart failure events or outpatient heart failure. The validity of ICD codes is very 
good23,24 and most heart failure patients diagnosed in the outpatient setting will eventually 
be hospitalized.23 Our lifetime heart failure risk estimate obviously may have been greater 
than one in four had we found all outpatient events and followed participants through age 
100. Yet, our focus on moderate to severe heart failure should not change the conclusion that 
greater achievement of Life’s Simple 7 in middle-age is associated with less heart failure 
risk. Furthermore, similar associations of Life’s Simple 7 with cardiac structure and function 
in those free of heart failure or myocardial infarction suggest that our findings are broadly 
generalizable.
Secondly the African Americans in ARIC lived in two centers (Jackson, MS and Forsyth 
County, NC), whereas the whites lived in Forsyth County, suburban Minneapolis, and 
Washington County, MD. Although this complicates direct comparisons of lifetime heart 
failure risk in African Americans versus whites, the ARIC African American participants 
clearly had poorer Life’s Simple 7 risk factors, which contributed greatly to their higher 
lifetime heart failure risk. Thus, African Americans appear to have a great potential for heart 
failure prevention by optimizing Life’s Simple 7.
Thirdly, we focused on a single measure of Life’s Simple 7 in middle-age, because we were 
interested in the potential of heart failure prevention starting in mid-life. During more than 2 
decades of follow-up, many participants’ Life’s Simple 7 categorization certainly would 
have changed, and this likely would have weakened the observed association with 
echocardiographic measures at Visit 5. In a future report, ARIC will examine the more 
complicated question of whether changes in Life’s Simple 7 levels are associated inversely 
with late-life cardiac structure and function.
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Greater achievement of AHA’s Life’s Simple 7 in middle-age is associated with a lower 
lifetime occurrence of heart failure and with greater preservation of cardiac structure and 
function in late life. Since ARIC is not a clinical trial, we cannot prove cause and effect, but 
all of the Life’s Simple 7 risk factors and health behaviors are believed to be causative, and 
clinical trial evidence supports the value of reducing most of them. To lessen the public 
health burden of heart failure,7 cardiovascular disease, and potentially other chronic 
diseases, health professionals need to encourage the public to optimize lifestyle-related risk 
factors before middle age.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• One in four middle-aged adults will develop heart failure if they survive to age 
85.
• Enabling patients to reach middle age with few cardiovascular risk factors will 
greatly preserve their cardiac function and reduce their lifetime risk of heart 
failure.
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Race-Specific Lifetime Risk of Heart Failure (HF) in Relation to Three Categories of an 
AHA Life’s Simple 7 Score, ARIC, 1987-2011
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Table 1
Heart Failure (HF) Incidence and Lifetime Risk in Relation to Number of Ideal AHA Life’s Simple 7 
Components, ARIC, 1987 to 2011


















(%), in absence 
of
MI (95% CI)∥(N) (%) Person-years
All
0 350 2.6 122 5,521 22.1 (18.5, 26.4) 1 (Ref) 45.1 (35.0, 52.0) 40.7 (28.7, 48.8)
1 1,996 14.8 558 35,499 15.7 (14.5, 17.1) 0.75 (0.43, 0.64) 39.0 (34.9, 42.1) 33.7 (29.2, 37.1)
2 3,432 25.5 688 64,742 10.6 (9.9, 11.5) 0.52 (0.43, 0.64) 28.0 (25.5, 30.0) 24.1 (21.4, 26.3)
3 3,587 26.6 523 71,444 7.3 (6.7, 8.0) 0.39 (0.31, 0.48) 23.1 (20.4, 25.1) 19.4 (16.7, 21.5)
4 2,467 18.3 236 51,219 4.6 (4.1, 5.2) 0.27 (0.22, 0.34) 16.6 (13.4, 19.1) 13.2 (10.0, 15.7)
5 1,234 9.2 71 26,666 2.7 (2.1, 3.4) 0.17 (0.13, 0.23)
6 379 2.8 20 8,291 2.4 (1.6, 3.7) 0.17 (0.11, 0.28) 12.3 (8.8, 15.2)§ 10.5 (7.1, 13.4)§
7 17 0.1 0 377 0 --
African Americans
0 144 4.4 56 2,200 25.5 (19.6, 33.1) 1 (Ref) 45.4 (33.1, 55.4) 45.9 (30.4, 57.9)
1 743 22.7 216 13,151 16.4 (14.4, 18.8) 0.72 (0.53, 0.97) 40.9 (33.8, 46.3) 36.8 (29.1, 42.6)
2 1,057 32.3 219 19,751 11.1 (9.7, 12.7) 0.50 (0.37, 0.68) 28.5 (23.9, 32.0) 25.0 (20.3, 28.8)
3 815 24.9 125 15,917 7.9 (6.6, 9.4) 0.37 (0.27, 0.51) 26.5 (19.9, 31.4) 24.7 (17.9, 29.8)
4 383 11.7 47 7,573 6.2 (4.7, 8.3) 0.31 (0.21, 0.46) 20.1 (10.6, 27.0) 16.9 (7.2, 24.0)
5 103 3.2 4 2,184 1.8 (6.9, 4.9) 0.10 (0.04, 0.28)
6 22 0.7 2 467 4.3 (1.1, 17.1) 0.23 (0.05, 0.96) 5.8 (1.1, 10.4)§ 5.9 (1.1, 10.6)§
7 1 0.0 0 22 0 --
Whites
0 206 2.0 66 3,321 19.9 (15.6, 25.3) 1 (Ref) 45.3 (30.5, 55.0) 37.6 (19.7, 48.6)
1 1,253 12.3 342 22,348 15.3 (13.8, 17.0) 0.76 (0.57, 1.00) 37.9 (33.0, 41.8) 31.8 (26.3, 36.0)
2 2,375 23.3 469 44,991 10.4 (9.5, 11.4) 0.53 (0.41, 0.70) 27.8 (24.8, 30.2) 23.6 (20.3, 26.1)
3 2,772 27.2 398 55,527 7.2 (6.5, 7.9) 0.39 (0.30, 0.52) 22.3 (19.3, 24.6) 18.2 (15.2, 20.5)
4 2,084 20.4 189 43,646 4.3 (3.8, 5.0) 0.27 (0.20, 0.36) 16.1 (12.7, 18.7) 12.6 (9.2, 15.2)
5 1,131 11.1 67 24,482 2.7 (2.2, 3.5) 0.19 (0.13, 0.26)
6 357 3.5 18 7,824 2.3 (1.4, 3.7) 0.17 (0.10, 0.29) 12.5 (8.9, 15.6)§ 10.7 (7.1, 13.8)§
7 16 0.2 0 355 0 --
AHA = American Heart Association; ARIC = Atherosclerosis Risk in Communities; CHD = coronary heart disease; CI = confidence interval; HF = 




Adjusted for age, sex, prevalent CHD, competing risk of death, and race (All).
‡
Lifetime risk (%), adjusted for risk of non-HF death, calculated starting at index age 45 years over a follow-up of 40 years (maximum age 85 
years).
§
Those with 5-7 ideal health metrics were combined due to few HF events.
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∥
Those with prevalent CHD or interim myocardial infarction events (N=1,761) are excluded.
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Table 2
Heart Failure (HF) Incidence and Lifetime Risk in Relation to Three Categories of an AHA Life’s Simple 7 











Lifetime HF Risk (%)
(95% CI)‡
Overall
Inadequate (0-4) 947 353 14,956 23.6 (21.3, 26.2) 1 (Ref) 48.6 (42.5, 53.3)
Average (5-9) 8,685 1,592 167,189 9.5 (9.1, 10.0) 0.45 (0.40, 0.51) 26.8 (25.1, 28.1)
Optimal (10-14) 3,830 273 81,613 3.3 (3.0, 3.8) 0.19 (0.16, 0.22) 14.4 (11.9, 16.4)
African Americans
Inadequate (0-4) 471 171 7,488 23.9 (20.7, 27.8) 1 (Ref) 48.0 (39.4, 54.7)
Average (5-9) 2,409 462 45,636 10.1 (9.2, 11.1) 0.46 (0.39, 0.55) 28.3 (24.9, 30.9)
Optimal (10-14) 388 28 8,141 3.4 (2.4, 5.0) 0.19 (0.12, 0.28) 14.8 (6.1, 21.6)
Whites
Inadequate (0-4) 476 174 7, 468 23.3 (20.1, 27.0) 1 (Ref) 49.4 (40.7, 55.5)
Average (5-9) 6,276 1,130 121,554 9.3 (8.8, 9.9) 0.43 (0.36, 0.51) 26.3 (24.4, 27.8)
Optimal (10-14) 3,442 245 73,473 3.3 (2.9, 3.8) 0.19 (0.15, 0.23) 14.3 (11.7, 16.4)
Women
Inadequate (0-4) 558 205 9,300 22.0 (19.2, 25.3) 1 (Ref) 48.7 (41.3, 54.8)
Average (5-9) 4,436 721 88,647 8.1 (7.6, 8.7) 0.42 (0.36, 0.50) 24.4 (22.2, 26.2)
Optimal (10-14) 2,354 137 51,128 2.7 (2.3, 3.2) 0.17 (0.13, 0.21) 13.0 (9.9, 15.7)
Men
Inadequate (0-4) 389 148 5,656 26.2 (22.3, 30.7) 1 (Ref) 49.1 (38.0, 56.1)
Average (5-9) 4,249 871 78,543 11.1 (10.4, 11.9) 0.49 (0.40, 0.59) 29.3 (26.6, 31.2)
Optimal (10-14) 1,476 136 30,485 4.5 (3.8, 5.3) 0.22 (0.17, 0.28) 16.2 (12.3, 19.3)
AHA = American Heart Association; ARIC = Atherosclerosis Risk in Communities; CHD = coronary heart disease; CI = confidence interval; HF = 




Adjusted for age, sex (except where stratified), race (except where stratified), prevalent CHD, and competing risk of death.
‡
Lifetime risk (%), adjusted for risk of death, calculated starting at index age 45 years over a follow-up of 40 years (maximum age 85 years).
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Table 3
Prevalences and Odds Ratios (OR) of Left Ventricular Hypertrophy, Diastolic Dysfunction, or Systolic 
Dysfunction, Among 4,855 ARIC Participants Free of Clinical Heart Failure and Myocardial Infarction in 
2011-2013, in Relation to an AHA Life’s Simple 7 Score in 1987-1989
Life’s Simple 7
Score
Left Ventricular Hypertrophy* Diastolic Dysfunction15† Systolic Dysfunction‡
Total N % OR (95% CI)§ % OR (95% CI)§ % OR (95% CI)§
Inadequate (0-4) 134 16.5 1 (Ref.) 27.1 1 (Ref.) 2.4
Average (5-9) 2666 11.1 0.63 (0.36, 1.10) 21.8 0.69 (0.43, 1.12) 1.9 1 (Ref.)∥
Optimal (10-14) 2055 6.7 0.37 (0.20, 0.66) 16.2 0.43 (0.26, 0.69) 1.2 0.79 (0.43, 1.44)
AHA = American Heart Association; ARIC = Atherosclerosis Risk in Communities; CI = confidence interval; N = number; OR = odds ratio.
*
Left ventricular hypertrophy defined as left ventricular mass indexed to body surface area >95 g/m2 in women and >115 g/m2 in men.
†
Diastolic dysfunction as reflected by an E/E’ ratio >15.
‡
Systolic dysfunction defined as left ventricular ejection fraction <50%.
§
Odds ratio is adjusted for visit 5 (2011-2013) non-response, as well as age, race, and sex.
∥
Inadequate and average were combined owing to few participants in the inadequate group.
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